Actively Recruiting
Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors
Led by Scientific Institute San Raffaele · Updated on 2024-11-29
70
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a monocentric observational study to explore the molecular structure of tumors in the thoracic cavity, focusing on non-small cell lung cancer (NSCLC). The study aims to better understand the lymphocytic infiltrate within lung tumors by collecting clinical data and biological samples from patients diagnosed with thoracic tumors. Participants will be patients over 18 years old who are candidates for surgical treatment of thoracic tumors. During hospitalization and surgery, clinical data and biological material such as blood and tumor tissue will be collected. There is only one hospital visit for these procedures, and no follow-up data collection after discharge. The study is planned to last three years. During the single hospital visit, participants will undergo standard clinical procedures related to their treatment. Researchers will isolate lymphocytes within 15 days from enrollment to surgery and analyze lymphocyte gene expression within 48 hours after surgery. The study focuses on detailed biological analysis without further interventions, and participant observation is limited to the surgery period.
CONDITIONS
Brief Title
The Lymphocytic Infiltrate of Lung Tumors.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to provide informed consent
- Men and women over the age of 18
- Patients candidates for surgical treatment diagnosed with thoracic tumors
You will not qualify if you...
- Previous chemotherapy for any cancer within the last 6 months
- Pregnant and/or breastfeeding women
- Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 15 days
Participants undergo surgical treatment for thoracic tumors during hospitalization. Biological samples and data are collected during this single hospital visit as part of standard clinical care.
1 hospital visit (in-person)
Trial Site Locations
Total: 1 location
1
Scientific Institute Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
Research Team
P
Pierluigi Novellis, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here